US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
イギリス
LSE
Roche Holding AG (0TDF) 銘柄情報

Roche Holding AG (0TDF)

28.44

0.00

(0.00%)

終了 6月7日 12:30AM

Roche Holding AG (0TDF) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

28.44

( - )

買値

28.44

売値

28.44

出来高

253

0.00 日の範囲 0.00

0.00 52 週間の範囲 0.00

時価総額

前日終値

28.44

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

US$ 1,013,510

発行済株式数

795,617,637

配当利回り

9.8 (3.11%)

PER

20.5

1 株当たり利益 (EPS)

16.04

歳入

63.36B

純利益

12.88B

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haematology, infectious diseases... Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haematology, infectious diseases, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagnostic instruments; and digital health solutions. The company was founded in 1896 and is based in Basel, Switzerland. 詳細を表示

セクター

-

業界

-

ウェブサイト

www.roche.com

本社

Basel, Switzerland

設立

1896

Roche Holding AG is listed in the sector of the ロンドン証券取引所 with ticker 0TDF. The last closing price for Roche was US$28.44. Over the last year, Roche shares have traded in a share price range of US$ 0.00 to US$ 0.00.

Roche currently has 795,617,637 shares in issue. The market capitalisation of Roche is US$22.63 billion. Roche has a price to earnings ratio (PE ratio) of 20.50.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

0TDF - Frequently Asked Questions (FAQ)

What is the current Roche Holding AG share price?

The current share price of Roche Holding AG is US$ 28.44

How many Roche Holding AG shares are in issue?

Roche Holding AG has 795,617,637 shares in issue

What is the market cap of Roche Holding AG?

The market capitalisation of Roche Holding AG is USD 22.63B

What is the 1 year trading range for Roche Holding AG share price?

Roche Holding AG has traded in the range of US$ 0.00 to US$ 0.00 during the past year

What is the PE ratio of Roche Holding AG?

The price to earnings ratio of Roche Holding AG is 20.5

What is the cash to sales ratio of Roche Holding AG?

The cash to sales ratio of Roche Holding AG is 4.14

What is the registered address of Roche Holding AG?

The registered address for Roche Holding AG is Grenzacherstrasse 124, Basel, Basel-Stadt, 4070

What is the Roche Holding AG website address?

The website address for Roche Holding AG is www.roche.com

ptk123

weedtrader420

weedtrader420 9分前

☝️🤕🖕🦷🦷🦷🦷 does anyone know a good dentist that puts teeth back in?😝

along4zride

along4zride 9分前

You do know new stock symbol will be associated with Fannie Mae if there is IPO right . Best case scenario for hopeful investor based on expected $142 new share IPO if a conversion would be allowed would be at current (FNMA) penny stock price at 23 OTC shares for 1 IPO share.

TieetCoolee

TieetCoolee 10分前

47's floated a sale of 3% to 15% of the 79.9% Government warrant equity. At max, that's 12.5% to current shareholders 20.01% and their balance will be allowed to expire while everyone's focused on 2028 elections, WATCH!

$FMCC~ $FNMA~

skitahoe

skitahoe 11分前

GGB, while I'd love to see someone get the better of Griffin, I doubt if it will cost him more than a couple days pocket change. If people like him, or AdamF ever got jail time for their acts it would be more meaningful. When they pay big penalties, they just become more famous for their misdeeds.

Drugdoctor

Drugdoctor 11分前

Sorry to hear about your comprehension issues. Maybe some memory pills will help with your old age problems.

barnstormer

barnstormer 11分前

Doc, don't know if you saw my recent post to Brazen, but appears we're on the same page here re needing a Flaskworks update.

okpj

At the same time, liquidmetal is recognized as a generic substance. I suppose they could use it accordingly, rather than the trademark?

People say all things about Apple. And I am not happy with all of their practices, but yet admire them for most of their practices.

I

KG21

My bad. I thought since CDH posts the same damn thing over and over and over and over.......that if I posted it a second time.......that maybe we would finally all get it. Did anyone else know that they've missed deadlines. Well, no schit!I know what he's going to post before he ever posts. I think

tisdal

tisdal 21分前

Prophetic Statement (PS): When Zion announces, shareholders will be singing "Happy Days"
CEO : [paraphrase]"I cannot tell how much oil, but we'll be Happy".

PS: There will be a shakeup in the board of directors.
Reality: John Brown dies. He is replaced by Mr. Dunn.

Doc logic

Doc logic 22分前

flipper44,

Time for approval or at least an update on Flaskworks development since the switch to the 2023 model was over two years ago. The last time they went two years on development it was an obvious lack of oversight that allowed an oversized unit to be built or this was done on

TieetCoolee

TieetCoolee 23分前

https://static-assets-1.truthsocial.com/tmtg:prime-ts-assets/media_attachments/files/116/705/027/546/587/180/small/19ea8f22288e98a6.jpg
https://truthsocial.com/@realDonaldTrump/116705027777737558
$FMCC~ $FNMA~

skitahoe

skitahoe 24分前

I'm not disagreeing with what the experts said, it's just a shame that the regulators wanted more of the same to approve it. Companies all too often try to shorten their trials and lower their costs and shoot themselves in the foot by doing so. The question is, would the FDA or any other agency co

manibiotech

manibiotech 26分前

Wow
And that’s why they “ voluntarily “ went to “OTC”
Your BS is so obvious .

wronginvestor

wronginvestor 30分前

If you step back from all the noise this latest PR is incredibly bad. Its full of grammar errors and unfinished sentences.

It confirms they have no banking facilities in the US.

Confirms the judgement.

Confirms they are not going to follow US laws to dea

GoodGuyBill

GoodGuyBill 32分前

Gary, you’re absolutely right about how the SEC treats the OTC. It’s been the financial equivalent of the wild west for years. That’s exactly why this case is so unusual. NWBO isn’t relying on the SEC at all. They went straight to federal court, hired Mitts, and built a record that forces accountabi

Ronnie Replay

Ronnie Replay 34分前

Beware. You are about to get a 15 paragraph response that is mostly copy and pasted.

Eli's Gone

Eli's Gone 35分前

Eli's Gone

Eli's Gone 35分前

ORCA

$3.00 WITH R/S.LMAO.I WILL BE WATCHING MONDAY PREMARKET.AS YOU SAID THIS::::$ILLR_ so why are you guys trying to spin what I’m saying when I said clowns I meant the group of idiots before this CEO came in you guys don’t even realize what is about to happen. OK can’t you read between the lines? Aren’

wronginvestor

wronginvestor 39分前

I think it was aimed at Electric Metals and maybe TAQA to try and keep those deals alive.

However I think it's likely both are dead now. Electric Metals has to make a statement that they got the monies as it's a material event for them. The fact they haven't done so yet speaks volume

ORCA

R/S HAS TO BE IN BY JUNE 30TH.THE ONLY WAY TO REACH $1.00.MONDAY IS THE 8TH.THE TIME IS NEAR.
Los Angeles, June 02, 2026 (GLOBE NEWSWIRE) -- Triller Group Inc (Nasdaq: ILLR; ILLRW) (“Triller” or the “Company”) today announced that, on Friday, May 29, 2026, the Nasdaq Hearings Panel (the “P

skitahoe

skitahoe 43分前

Arguing about the effectiveness of DCVax-L is a fool's errand if you fail to consider what occurs when other therapeutics are added. A 13% survival rate at 5 years is well over the 5% with the SOC, but at UCLA Dr. Liau and her team have pushed it to 50% in a small trial and you know Dr. Liau wants

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。